Back to
CITADEL ADVISORS LLC
CLMT
Showing 1 of 23 quarters
Position history for
CITADEL ADVISORS LLC's holdings in CALUMET SPECIALTY PRODS PART
As of its Q2 2024 13F, Citadel Advisors held 138,575 shares of CLMT (Calumet Specialty Products Part), worth $2.2M. Citadel Advisors' 13F filings listed CLMT from Q2 2020 to Q2 2024, 17 quarterly filings.
Final Value
$0
Final Shares
0
Total Value Change
$0
Total Shares Change
0
Quarter-by-Quarter History